Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update

Go back to Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update
(NASDAQ: VVOS) Delayed: 0.50 +0.05 (11.11%)
Previous Close $0.45    52 Week High
Open $0.47    52 Week Low
Day High $0.53    P/E N/A 
Day Low $0.46    EPS
Volume 470,497